Conestoga Capital Advisors LLC Raises Holdings in Stevanato Group S.p.A. (NYSE:STVN)

Conestoga Capital Advisors LLC grew its stake in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 1.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,189,926 shares of the company's stock after buying an additional 106,930 shares during the quarter. Stevanato Group makes up 2.5% of Conestoga Capital Advisors LLC's portfolio, making the stock its 14th biggest holding. Conestoga Capital Advisors LLC owned 2.70% of Stevanato Group worth $167,238,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Van Berkom & Associates Inc. bought a new position in shares of Stevanato Group during the fourth quarter worth $39,000. Johnson Financial Group Inc. bought a new position in shares of Stevanato Group during the 4th quarter valued at approximately $41,000. Wells Fargo & Company MN lifted its position in Stevanato Group by 680.3% in the fourth quarter. Wells Fargo & Company MN now owns 3,246 shares of the company's stock worth $71,000 after buying an additional 2,830 shares during the last quarter. PNC Financial Services Group Inc. boosted its stake in Stevanato Group by 1,457.6% during the fourth quarter. PNC Financial Services Group Inc. now owns 5,654 shares of the company's stock worth $123,000 after buying an additional 5,291 shares during the period. Finally, Tower Research Capital LLC TRC increased its position in Stevanato Group by 202.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,413 shares of the company's stock valued at $162,000 after acquiring an additional 4,965 shares during the last quarter.

Stevanato Group Trading Down 1.7%

Shares of Stevanato Group stock traded down €0.42 ($0.48) on Wednesday, hitting €23.68 ($27.22). 342,800 shares of the company traded hands, compared to its average volume of 340,188. The company has a current ratio of 1.83, a quick ratio of 1.26 and a debt-to-equity ratio of 0.22. The company has a market cap of $7.17 billion, a PE ratio of 46.43, a PEG ratio of 2.30 and a beta of 0.53. The stock's 50 day moving average price is €22.61 and its 200-day moving average price is €21.68. Stevanato Group S.p.A. has a 52 week low of €16.56 ($19.03) and a 52 week high of €25.75 ($29.60).

Stevanato Group Increases Dividend

The company also recently announced an annual dividend, which will be paid on Thursday, July 17th. Shareholders of record on Thursday, June 5th will be issued a $0.0613 dividend. This represents a dividend yield of 0.3%. This is a boost from Stevanato Group's previous annual dividend of $0.05. The ex-dividend date is Thursday, June 5th.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on STVN shares. Stephens upgraded shares of Stevanato Group to a "strong-buy" rating in a report on Monday, April 21st. William Blair reissued an "outperform" rating on shares of Stevanato Group in a research note on Friday, March 7th. Finally, UBS Group cut their target price on Stevanato Group from $24.00 to $23.50 and set a "neutral" rating on the stock in a research note on Friday, March 7th. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Stevanato Group presently has a consensus rating of "Moderate Buy" and a consensus target price of €25.70 ($29.54).

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.